Scoring Abdominal Symptoms in People with Cystic Fibrosis.

Autor: Tabori, Harold^1,2,3 (AUTHOR) gabor.dunay@uk-brandenburg.de, Barucha, Anton^1,3,4 (AUTHOR), Zagoya, Carlos¹ (AUTHOR), Duckstein, Franziska¹ (AUTHOR), Dunay, Gabor A.^3,5 (AUTHOR), Sadrieh, Pauline^1,3 (AUTHOR), Polte, Louise^1,3 (AUTHOR), Mainz, Jochen G.^1,3 (AUTHOR) j.mainz@uk-brandenburg.de

Publikováno v: Journal of Clinical Medicine. Mar2024, Vol. 13 Issue 6, p1650. 27p.

Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/ tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire.

Autor: Mainz, Jochen G., Barucha, Anton, Pu Huang, Bechinger, Lilith, Duckstein, Franziska, Polte, Louise, Sadrieh, Pauline, Nährlich, Lutz, Eickmeier, Olaf, Van Dullemen, Suzanne, Eschenhagen, Patience, Schwarz, Carsten, Lüth, Stefan, Zagoya, Carlos, Graepler-Mainka, Ute

Publikováno v: Frontiers in Pharmacology; 2023, p1-12, 12p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score.

Autor: Mainz JG; Cystic Fibrosis Center, Brandenburg Medical School (MHB) University, Klinikum Westbrandenburg, Brandenburg an der Havel, Germany.; Faculty of Health Sciences Joint Faculty of the Brandenburg University of Technology Cottbus-Senftenberg, The Brandenburg Medical School Theodor Fontane and the University of Potsdam, Potsdam, Germany., Zagoya C; Cystic Fibrosis Center, Brandenburg Medical School (MHB) University, Klinikum Westbrandenburg, Brandenburg an der Havel, Germany., Polte L; Cystic Fibrosis Center, Brandenburg Medical School (MHB) University, Klinikum Westbrandenburg, Brandenburg an der Havel, Germany., Naehrlich L; Department of Pediatrics, Justus-Liebig-University Giessen, Giessen, Germany.; Universities of Giessen and Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Giessen, Germany., Sasse L; Department of Pediatrics, Justus-Liebig-University Giessen, Giessen, Germany., Eickmeier O; Christiane Herzog CF-Zentrum Frankfurt am Main, Universitätsklinikum Frankfurt am Main CF-Zentrum, Frankfurt am Main, Germany., Smaczny C; Christiane Herzog CF-Zentrum Frankfurt am Main, Universitätsklinikum Frankfurt am Main CF-Zentrum, Frankfurt am Main, Germany., Barucha A; Cystic Fibrosis Center, Brandenburg Medical School (MHB) University, Klinikum Westbrandenburg, Brandenburg an der Havel, Germany., Bechinger L; Cystic Fibrosis Center, Brandenburg Medical School (MHB) University, Klinikum Westbrandenburg, Brandenburg an der Havel, Germany., Duckstein F; Cystic Fibrosis Center, Brandenburg Medical School (MHB) University, Klinikum Westbrandenburg, Brandenburg an der Havel, Germany., Kurzidim L; Cystic Fibrosis Center, Brandenburg Medical School (MHB) University, Klinikum Westbrandenburg, Brandenburg an der Havel, Germany.; CF-Zentrum Westbrandenburg, Campus Potsdam, Klinikum Westbrandenburg, Potsdam, Germany., Eschenhagen P; CF-Zentrum Westbrandenburg, Campus Potsdam, Klinikum Westbrandenburg, Potsdam, Germany., Caley L; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom., Peckham D; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom.; Adult Cystic Fibrosis Unit, St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Schwarz C; CF-Zentrum Westbrandenburg, Campus Potsdam, Klinikum Westbrandenburg, Potsdam, Germany.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2023 May 03; Vol. 14, pp. 1207356. Date of Electronic Publication: 2023 May 03 (Print Publication: 2023).